NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 168 filers reported holding NOVOCURE LTD in Q4 2018. The put-call ratio across all filers is 0.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $15,213,000 | +17.0% | 87,918 | -24.8% | 0.54% | +9.9% |
| Q3 2020 | $13,006,000 | +66.6% | 116,845 | -11.2% | 0.49% | +64.0% |
| Q2 2020 | $7,806,000 | +7.9% | 131,637 | +22.5% | 0.30% | -9.2% |
| Q1 2020 | $7,235,000 | -20.1% | 107,438 | 0.0% | 0.33% | -4.4% |
| Q4 2019 | $9,054,000 | +20.0% | 107,438 | +6.4% | 0.34% | +4.0% |
| Q3 2019 | $7,548,000 | +120.8% | 100,932 | +86.7% | 0.33% | +135.0% |
| Q2 2019 | $3,419,000 | +7.6% | 54,074 | -18.0% | 0.14% | +8.5% |
| Q1 2019 | $3,177,000 | +287.4% | 65,964 | +169.2% | 0.13% | +268.6% |
| Q4 2018 | $820,000 | – | 24,500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $77,833,000 | 15.51% |
| HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
| Darsana Capital Partners LP | 700,000 | $155,274,000 | 4.42% |
| MORGAN JESS S & CO INC | 23,775 | $5,274,000 | 3.47% |
| Soleus Capital Management, L.P. | 98,975 | $21,955,000 | 3.38% |
| Montanaro Asset Management Ltd | 116,650 | $25,875,000 | 3.26% |
| Taylor Frigon Capital Management LLC | 31,035 | $6,884,000 | 2.15% |
| Rhenman & Partners Asset Management AB | 120,000 | $26,618,000 | 1.81% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $2,218,000 | 1.33% |
| Derbend Asset Management | 5,789 | $1,284,000 | 1.20% |